Project Ambition

The MycoSynVac project aims at using cutting-edge synthetic biology methodologies to engineer Mycoplasma pneumoniae as a universal chassis for vaccination.

 

  • Dr Maria Lluch, MycoSynVac co-coordinator, winner of the 2016 Derrick Edward Award by the International Organisation for Mycoplasmology

  • MycoSynVac 1st Annual Meeting took place in Bordeaux on October 18th and 19th 2016

  • Tools for genome engineering course.

    The course will be hosted in 2018 at INRA, Bordeaux. More information coming soon. Stay tuned!

  • Current production processes of vaccines based on mycoplasma are very irreproducible and prone to contamination by animal viruses.

  • Infection caused by Mycoplasma species on livestock result in multi-million losses in Europe and USA

  • Dr Carmen DE VICENTE COLL
    Research Programme Officer, European Commission

  • Whole-Cell Modeling Course
    The goal of the 2017 Whole-Cell Modeling Course is to provide young investigators cutting-edge training in large-scale dynamical modeling and model integration.

  • 2nd Review Meeting took place on 17th May 2017 in Brussels

  • Disease & Impact

  • Vaccine Symposium in Nijmegen
    November 15th 2017 from 9:00am to 6pm
    Registration Open!